載入...
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
A major barrier for cancer immunotherapy is the presence of suppressive cell populations in cancer patients, such as myeloid-derived suppressor cells (MDSC) and tumor-associated macrophages (TAM), which contribute to the immunosuppressive microenvironment that promotes tumor growth and metastasis. T...
Na minha lista:
| 發表在: | Cancer Immunol Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323929/ https://ncbi.nlm.nih.gov/pubmed/25370534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0036 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|